Aztreonam

Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

Gram-negative bacterial pneumonia
Skin and soft tissue infections (caused by Gram-negative bacilli)
Complicated and uncomplicated urinary tract infections
Intra-abdominal infections (in combination with metronidazole)
Septicemia (cause by Gram-negative bacilli)
Gynecologic infections (in combination with anaerobic coverage)
Nebulized aztreonam is indicated for treatment of respiratory symptoms in cystic fibrosis (CF patients with FEV1 of 25-75% of predicted) with P. aeruginosa

Alternative therapy for treatment of Gram-negative infections in patients with severe allergies

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.